Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Mar 16, 2018

30597_dirs_2018-03-15_5dbcb498-66be-4be8-beea-8d1e3673d8e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-03-14

Reporting Person: LIDGARD GRAHAM PETER (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-14 Common Stock M 7163 $13.96 Acquired 201112 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-14 Stock Option (right to buy) $13.96 M 7163 Disposed 2024-02-24 Common Stock (7163) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12340 Indirect

Footnotes

F1: This option vests and becomes exercisable in four equal annual installments beginning on February 24, 2015.